کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
6151184 | 1231509 | 2014 | 6 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Clinical trials transparency and the Trial and Experimental Studies Transparency (TEST) act
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
FDAAAFDAEMAICMJENIHHHSClinical trials - آزمایشات بالینیUS Food and Drug Administration - اداره غذا و داروی ایالات متحدهDeclaration of Helsinki - اعلامیه هلسینکیCompliance - انطباقIdeS - ایده هاDoH - بلهTest - تستWorld Health Organization - سازمان بهداشت جهانیTrips - سفرهاTransparency - شفافیتIndustries - صنایعNIH, National Institutes of Health - مؤسسه ملی سلامتUS Department of Health and Human Services - وزارت بهداشت و خدمات انسانی ایالات متحدهInternational Committee of Medical Journal Editors - کمیته بین المللی ویراستاران مجله پزشکیWHO - کهResearch reporting - گزارش تحقیق
موضوعات مرتبط
علوم پزشکی و سلامت
پزشکی و دندانپزشکی
پزشکی و دندانپزشکی (عمومی)
پیش نمایش صفحه اول مقاله
![عکس صفحه اول مقاله: Clinical trials transparency and the Trial and Experimental Studies Transparency (TEST) act Clinical trials transparency and the Trial and Experimental Studies Transparency (TEST) act](/preview/png/6151184.png)
چکیده انگلیسی
Clinical trial research is the cornerstone for successful advancement of medicine that provides hope for millions of people in the future. Full transparency in clinical trials may allow independent investigators to evaluate study designs, perform additional analysis of data, and potentially eliminate duplicate studies. Current regulatory system and publishers rely on investigators and pharmaceutical industries for complete and accurate reporting of results from completed clinical trials. Legislation seems to be the only way to enforce mandatory disclosure of results. The Trial and Experimental Studies Transparency (TEST) Act of 2012 was introduced to the legislators in the United States to promote greater transparency in research industry. Public safety and advancement of science are the driving forces for the proposed policy change. The TEST Act may benefit the society and researchers; however, there are major concerns with participants' privacy and intellectual property protection.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Contemporary Clinical Trials - Volume 37, Issue 2, March 2014, Pages 219-224
Journal: Contemporary Clinical Trials - Volume 37, Issue 2, March 2014, Pages 219-224
نویسندگان
Ilana Logvinov,